Mini Review Volume 13 Issue 2
Chemical Biological Defense Department, Defense Threat Reduction Agency, USA
Correspondence: Akbar S Khan, Chemical Biological Defense Department, Defense Threat Reduction Agency, Fort Belvoir, Virginia, USA
Received: May 20, 2025 | Published: June 4, 2025
Citation: Khan AS. Scope and impact of artificial intelligence and machine learning & deep learning in biology. J Bacteriol Mycol Open Access. 2025;13(2):86-87. DOI: 10.15406/jbmoa.2025.13.00403
Artificial Intelligence (AI), Machine Learning (ML), and Deep Learning (DL) are transforming the landscape of biological and biomedical research. These cutting-edge technologies are enabling faster, more accurate data interpretation, drug discovery, and personalized treatment approaches. AI/ML/DL tools can efficiently analyze large-scale datasets from genomics, proteomics, and imaging, while also supporting predictive modeling for protein structure, drug efficacy, and gene editing. From enhancing precision medicine to enabling advances in synthetic biology and CRISPR technologies, AI-driven approaches are becoming integral to innovation in life sciences. Despite their immense potential, challenges related to data quality, interpretability, and ethical concerns remain. This paper highlights key applications, current challenges, and future directions, emphasizing the need for integration with experimental biology and the development of a skilled workforce to fully leverage these tools in biological research.
Keywords: artificial intelligence, machine learning, deep learning, drug discovery, bioinformatics, genomics, proteomics, synthetic biology, systems biology, computational biology
Artificial intelligence (AI), Machine Learning (ML) & Deep Learning (DL) currently a cutting-edge concept, have the huge potential to improve the quality of life of human beings. The fields of AI, ML & DL (1, 2 and 3) and biological research are becoming more intertwined, and methods for extracting and applying the information stored in live organisms are constantly being extracted refined. Basically AI is used to create intelligent machines. ML then allowing machines to learn from data, and deep learning is a specific type of ML that uses powerful neural networks to learn complex patterns. As the field of AI, ML & DL matures with more trained algorithms, the potential of its application in epidemiology, the study of host–pathogen interactions and drug designing widens. AI, ML & DL (1, 2 and 3) together now are being applied in several fields of drug discovery, customized medicine, gene editing, radiography, image processing and medication management. More precise diagnosis and cost-effective treatment will be possible in the near future due to the application of AI-based technologies.
Here's a breakdown of their impact:
To tackle grand challenging problems across the biological sciences, researchers increasingly are turning to the development and adoption of AI/ML methods. AI/ML includes any computational tool that mimics intelligence and the ability to learn from data to derive inferences. These methods are powerful tools for analyzing, synthesizing, and integrating large and complex datasets, developing predictive models, and designing and deploying bio-inspired innovations (Figure 1). Unique aspects of information processing in biological systems and the complexity of biological data can also inform and inspire new developments in AI/ML. In addition, AI-enabled research requires a trained workforce prepared to use, develop, and validate appropriate AI/ML approaches and supporting technologies tailored for biological systems.
None.
The author declares that there are no conflicts of interest.
©2025 Khan. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.